Financial reports
10-Q
2017 Q3
Quarterly report
13 Nov 17
10-Q
2017 Q2
Quarterly report
11 Aug 17
10-Q
2017 Q1
Quarterly report
15 May 17
10-K
2016 FY
Annual report
30 Mar 17
10-Q
2016 Q3
Quarterly report
14 Nov 16
10-Q
2016 Q2
Quarterly report
12 Aug 16
10-Q
2016 Q1
Quarterly report
13 May 16
10-K
2015 FY
Annual report
28 Mar 16
10-Q
2015 Q3
Quarterly report
13 Nov 15
Current reports
8-K
Changes in Registrant's Certifying Accountant
4 Aug 16
8-K
Departure of Directors or Certain Officers
26 Oct 15
8-K
Departure of Directors or Certain Officers
5 Dec 13
8-K
Departure of Directors or Certain Officers
6 Sep 13
8-K
Departure of Directors or Certain Officers
20 Oct 11
8-K
Amendments to Articles of Incorporation or Bylaws
15 Jul 11
8-K
Other Events
30 Mar 11
8-K
Entry into a Material Definitive Agreement
4 Oct 10
8-K
Amendments to Articles of Incorporation or Bylaws
7 Sep 10
8-K
Other Events
6 Apr 10
Registration and prospectus
15-12G
Securities registration termination
22 Mar 18
D/A
Indefinite amount in investment fund, sold $635K, 2 investors
7 Aug 17
D/A
Indefinite amount in investment fund, sold $635K, 2 investors
4 Aug 16
D/A
Indefinite amount in investment fund, sold $635K, 2 investors
11 May 15
D
Indefinite amount in investment fund, sold $135K, 1 investor
30 Mar 12
POS AM
Prospectus update (post-effective amendment)
5 Jul 11
424B3
Prospectus supplement
3 May 11
S-1/A
IPO registration (amended)
22 Apr 11
424B3
Prospectus supplement
7 Apr 11
424B3
Prospectus supplement
7 Feb 11
Other
CT ORDER
Confidential treatment order
29 Jun 17
CT ORDER
Confidential treatment order
24 May 16
CT ORDER
Confidential treatment order
5 Apr 16
CT ORDER
Confidential treatment order
28 Apr 15
CT ORDER
Confidential treatment order
16 Jul 14
CT ORDER
Confidential treatment order
23 Jun 14
CT ORDER
Confidential treatment order
11 Jun 14
UPLOAD
Letter from SEC
25 Feb 14
CORRESP
Correspondence with SEC
27 Jan 14
UPLOAD
Letter from SEC
24 Dec 13